Interactive Financial Charts Not Available

Equasens (EQS) | Financial Analysis & Statements

Equasens | Mid-cap | Healthcare

€51.40

0.78%

Equasens vs Cegedim S.A Equasens vs Abl Diagnostics Equasens vs Smaio S.A Equasens vs Intrasense S.A Equasens vs Ama Corp Plc Equasens vs CAC 40 | Market

TL;DR Income Statement Balance Sheet Cash Flow Key Ratios Peer Comparison

TL;DR: Financial Overview - Revenue, Profits & Key Metrics

Income Metrics

Balance Sheet Metrics

Total Assets 394.0M

Total Liabilities 166.4M

Shareholders Equity 227.6M

Debt to Equity 0.73

Cash Flow Metrics

Revenue & Profitability Trend

Interactive Financial Charts Not Available

This page uses interactive financial charts and dynamic data visualization tools that require JavaScript. For detailed financial analysis:

Available Financial Data:

Income statements (annual and quarterly)
Balance sheets with asset and liability details
Cash flow statements and free cash flow analysis
Key financial ratios and performance metrics
Peer comparison and industry benchmarking

All financial data is displayed in accessible table format below. Use the table headers and structure to analyze trends and compare metrics across different periods.

Equasens Income Statement From 2019 to 2023

Metric	2023	2022	2021	2020	2019
Revenue i	219.8M	214.1M	193.1M	171.8M	158.6M
Cost of Goods Sold i	69.1M	68.5M	59.3M	52.4M	50.3M
Gross Profit i	150.6M	145.6M	133.8M	119.3M	108.2M
Gross Margin % i	68.5%	68.0%	69.3%	69.5%	68.3%
Operating Expenses
Research & Development i	-	-	-	-	-
Selling, General & Administrative i	-	-	-	-	-
Other Operating Expenses i	3.7M	4.2M	4.1M	3.6M	3.6M
Total Operating Expenses i	3.7M	4.2M	4.1M	3.6M	3.6M
Operating Income i	55.8M	56.2M	50.3M	46.6M	40.8M
Operating Margin % i	25.4%	26.3%	26.0%	27.2%	25.8%
Non-Operating Items
Interest Income i	3.9M	1.6M	921.0K	1.3M	1.3M
Interest Expense i	669.0K	679.0K	589.0K	571.0K	503.0K
Other Non-Operating Income	-	-	-	-	-
Pre-tax Income i	57.4M	54.4M	51.9M	45.9M	42.3M
Income Tax i	9.7M	6.2M	10.6M	13.4M	13.3M
Effective Tax Rate % i	16.9%	11.4%	20.5%	29.2%	31.4%
Net Income i	48.9M	48.7M	41.2M	32.7M	30.4M
Net Margin % i	22.2%	22.7%	21.3%	19.0%	19.1%
Key Metrics
EBITDA i	72.2M	69.5M	64.4M	55.7M	50.8M
EPS (Basic) i	€3.13	€3.09	€2.60	€2.04	€1.89
EPS (Diluted) i	€3.10	€3.06	€2.58	€2.02	€1.87
Basic Shares Outstanding i	15031235	15031697	15019717	15068964	15025315
Diluted Shares Outstanding i	15031235	15031697	15019717	15068964	15025315

Income Statement Trend

Equasens Balance Sheet From 2019 to 2023

Metric	2023	2022	2021	2020	2019
Assets
Current Assets
Cash & Equivalents i	18.4M	23.4M	34.8M	33.6M	21.4M
Short-term Investments i	36.3M	44.6M	30.0M	29.7M	29.2M
Accounts Receivable i	52.8M	46.5M	37.4M	31.8M	34.6M
Inventory i	10.3M	9.3M	8.9M	6.8M	4.4M
Other Current Assets	-	-	-	1.0K	-
Total Current Assets i	132.2M	137.2M	122.3M	110.9M	97.6M
Non-Current Assets
Property, Plant & Equipment i	6.9M	852.0K	23.5M	22.1M	17.7M
Goodwill i	220.5M	204.6M	206.9M	167.7M	129.5M
Intangible Assets i	40.1M	38.5M	39.5M	36.6M	30.0M
Long-term Investments	-	-	-	-	-
Other Non-Current Assets	2.0K	-	-1.0K	-	1.0K
Total Non-Current Assets i	261.8M	213.6M	207.7M	184.9M	160.5M
Total Assets i	394.0M	350.8M	330.0M	295.8M	258.1M
Liabilities
Current Liabilities
Accounts Payable i	16.1M	16.8M	16.3M	14.2M	13.4M
Short-term Debt i	22.3M	18.1M	20.7M	16.8M	10.0M
Current Portion of Long-term Debt	-	-	-	-	-
Other Current Liabilities	67.6M	61.2M	54.3M	49.3M	47.6M
Total Current Liabilities i	108.1M	98.1M	94.1M	81.4M	72.1M
Non-Current Liabilities
Long-term Debt i	46.7M	48.4M	59.4M	55.0M	47.5M
Deferred Tax Liabilities i	1.6M	1.5M	1.4M	855.0K	635.0K
Other Non-Current Liabilities	2.7M	97.0K	325.0K	4.3M	1.3M
Total Non-Current Liabilities i	58.3M	55.9M	70.7M	65.5M	54.0M
Total Liabilities i	166.4M	154.0M	164.7M	146.8M	126.2M
Equity
Common Stock i	3.0M	3.0M	3.0M	3.0M	3.0M
Retained Earnings i	47.0M	46.4M	39.1M	30.7M	28.4M
Treasury Stock i	-	-	-	-	-
Other Equity	-	-	-	-	-
Total Shareholders Equity i	227.6M	196.8M	165.2M	149.0M	131.9M
Key Metrics
Total Debt i	69.1M	66.5M	80.0M	71.8M	57.5M
Working Capital i	24.1M	39.0M	28.2M	29.5M	25.4M

Balance Sheet Composition

Equasens Cash Flow Statement From 2019 to 2023

Metric	2023	2022	2021	2020	2019
Operating Activities
Net Income i	55.2M	55.2M	50.3M	46.1M	40.8M
Depreciation & Amortization i	-	-	-	-	-
Stock-Based Compensation i	352.0K	352.0K	-	-	-
Working Capital Changes i	-2.7M	-6.1M	-4.3M	6.4M	3.9M
Operating Cash Flow i	52.8M	49.8M	46.3M	52.6M	44.8M
Investing Activities
Capital Expenditures i	-	-	-	-	524.0K
Acquisitions i	-8.3M	0	-25.9M	-19.5M	-14.1M
Investment Purchases i	-58.5M	-24.5M	0	0	-2.6M
Investment Sales i	34.7M	12.1M	0	0	0
Investing Cash Flow i	-32.1M	-12.4M	-26.0M	-19.5M	-16.1M
Financing Activities
Share Repurchases i	-5.2M	-7.3M	-5.2M	0	-
Dividends Paid i	-17.3M	-15.8M	-14.3M	-13.5M	-12.8M
Debt Issuance i	22.0M	7.8M	26.9M	22.2M	15.4M
Debt Repayment i	-20.2M	-17.8M	-15.2M	-11.6M	-8.8M
Financing Cash Flow i	-15.5M	-35.1M	-9.1M	5.1M	-17.3M
Free Cash Flow i	39.3M	46.8M	37.1M	27.5M	23.7M
Net Change in Cash i	5.2M	2.2M	11.3M	38.2M	11.4M

Cash Flow Trend

Equasens Key Financial Ratios

Valuation Ratios

P/E Ratio (TTM) 16.53

Forward P/E 17.36

Price to Book 3.34

Price to Sales 3.56

PEG Ratio 17.36

Profitability Ratios

Profit Margin 16.72%

Operating Margin 26.51%

Return on Equity 16.13%

Return on Assets 7.04%

Financial Health

Current Ratio 1.21

Debt to Equity 25.65

Beta 0.88

Per Share Data

EPS (TTM) €3.11

Book Value per Share €15.40

Revenue per Share €14.42

Peer Financial Comparison

Company	Market Cap	P/E Ratio	P/B Ratio	ROE	Profit Margin	Debt/Equity
eqs	772.6M	16.53	3.34	16.13%	16.72%	25.65
Cegedim S.A	143.2M	92.86	0.54	-4.95%	-2.25%	115.34
Abl Diagnostics	86.8M	535.00	11.51	4.00%	4.86%	34.10
Smaio S.A	36.9M	16.30	4.98	-29.15%	-42.73%	33.75
Intrasense S.A	15.2M	-	9.16	-126.47%	-251.78%	84.95
Ama Corp Plc	14.4M	-	5.72	-176.91%	-294.90%	159.28

Financial data is updated regularly. All figures are in the company's reporting currency.